HB Biotech, Inc. — Form D

HB Biotech, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-15. The offering totals $11.0M, of which $7.8M was reported sold. Industry: Other.

Offering

• Filed: 2022-12-15
• Form: D
• Accession: 0001958314-22-000002
• Industry: Other
• Exemptions: 06b
• Total offering: $11.0M
• Amount sold: $7.8M
• Remaining: $3.2M
• Investors: 17
• Date of first sale: 2022-12-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-467639

Issuer

• Name: HB Biotech, Inc.
• CIK: 0001958314
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 515 WEST 20TH STREET, NEW YORK, NY, 10011
• Phone: 2126477777

Officers, directors & promoters (2)

More

• CIK 1958314 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search